Peter Boström
peter.bostrom@utu.fi ORCID identifier: https://orcid.org/0000-0003-3647-0015 |
Publications
- Initiation of robot-assisted radical prostatectomies in Finland: Impact on centralization and quality of care (2016)
- Scandinavian Journal of UrologyUrologic Oncology: Seminars and Original Investigations
(A1 Refereed original research article in a scientific journal) - Intravesical Bacillus Calmette-Guerin Versus Combination of Epirubicin and Interferon-alpha 2a in Reducing Recurrence of Non-Muscle-invasive Bladder Carcinoma: FinnBladder-6 Study (2016)
- European UrologyAnnals of Oncology
(A1 Refereed original research article in a scientific journal) - Longitudinal modeling of ultrasensitive and traditional prostate-specific antigen and prediction of biochemical recurrence after radical prostatectomyUpdate on novel imaging techniques for the detection of lymph node metastases in bladder cancer (2016)
- Scientific Reports
(A1 Refereed original research article in a scientific journal) - Loss of PTEN expression in ERG-negative prostate cancer predicts secondary therapies and leads to shorter disease-specific survival time after radical prostatectomy. (2016)
- Modern Pathology
(A1 Refereed original research article in a scientific journal) - Patient-specific pharmacokinetic parameter estimation on dynamic contrast-enhanced MRI of prostate: Preliminary evaluation of a novel AIF-free estimation method (2016)
- Journal of Magnetic Resonance Imaging
(A1 Refereed original research article in a scientific journal) - Relaxation along fictitious field, diffusion-weighted imaging, and T2 mapping of prostate cancer: Prediction of cancer aggressiveness (2016)
- Magnetic Resonance in MedicineMinerva Urologica e Nefrologica
(A1 Refereed original research article in a scientific journal) - Rotating frame relaxation imaging of prostate cancer: Repeatability, cancer detection, and Gleason score prediction (2016)
- Magnetic Resonance in Medicine
(A1 Refereed original research article in a scientific journal) - Stratification of aggressive prostate cancer from indolent disease-Prospective controlled trial utilizing expression of 11 genes in apparently benign tissue (2016)
(A1 Refereed original research article in a scientific journal) - Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatment (2016)
(A1 Refereed original research article in a scientific journal) - (2016)
(A2 Refereed review article in a scientific journal )



